UA115087C2 - Кристалічна форма триетиламінової солі заміщеної тіазолілоцтової кислоти - Google Patents
Кристалічна форма триетиламінової солі заміщеної тіазолілоцтової кислотиInfo
- Publication number
- UA115087C2 UA115087C2 UAA201509929A UAA201509929A UA115087C2 UA 115087 C2 UA115087 C2 UA 115087C2 UA A201509929 A UAA201509929 A UA A201509929A UA A201509929 A UAA201509929 A UA A201509929A UA 115087 C2 UA115087 C2 UA 115087C2
- Authority
- UA
- Ukraine
- Prior art keywords
- crystalline form
- triethylamine salt
- acid triethylamine
- substituted
- thiazolylacetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
- C07D277/593—Z being doubly bound oxygen or doubly bound nitrogen, which nitrogen is part of a possibly substituted oximino radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Abstract
Винахід стосується кристалічної форми триетиламінової солі (2Z)-2-(2-аміно-5-хлоротіазол-4-іл)-2-(3-N-трет-бутоксикарбоніламінопропоксііміно)оцтової кислоти, а також способів і проміжних сполук для її одержання, причому зазначена кристалічна форма придатна як проміжна сполука для одержання антибіотиків глікопептид-цефалоспоринового ряду з поперечним міжмолекулярним зв'язком.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361779091P | 2013-03-13 | 2013-03-13 | |
| PCT/US2014/021080 WO2014164187A1 (en) | 2013-03-13 | 2014-03-06 | Crystalline form of a substituted thiazolylacetic acid triethylamine salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA115087C2 true UA115087C2 (uk) | 2017-09-11 |
Family
ID=50382685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201509929A UA115087C2 (uk) | 2013-03-13 | 2014-03-06 | Кристалічна форма триетиламінової солі заміщеної тіазолілоцтової кислоти |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9139542B2 (uk) |
| EP (1) | EP2970164B1 (uk) |
| JP (2) | JP6404309B2 (uk) |
| KR (1) | KR20150126368A (uk) |
| CN (1) | CN105121417B (uk) |
| AU (1) | AU2014249611B2 (uk) |
| BR (1) | BR112015022600A2 (uk) |
| CA (1) | CA2902724A1 (uk) |
| EA (1) | EA027911B1 (uk) |
| ES (1) | ES2634019T3 (uk) |
| GE (1) | GEP201706779B (uk) |
| HK (1) | HK1214596A1 (uk) |
| IL (1) | IL240600A0 (uk) |
| MD (1) | MD4719C1 (uk) |
| MX (1) | MX351963B (uk) |
| PH (1) | PH12015502067A1 (uk) |
| SG (1) | SG11201507221VA (uk) |
| TW (1) | TWI627165B (uk) |
| UA (1) | UA115087C2 (uk) |
| WO (1) | WO2014164187A1 (uk) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3139772A1 (en) * | 2019-05-31 | 2020-12-03 | Jeong Un HWANG | Novel crystal form of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284631A (en) | 1978-07-31 | 1981-08-18 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them |
| US4372952A (en) | 1978-07-31 | 1983-02-08 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US4341775A (en) | 1978-09-11 | 1982-07-27 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| GB2033377B (en) | 1978-09-11 | 1983-05-05 | Fujisawa Pharmaceuticalco Ltd | Cephem compounds and processes for preparation thereof |
| US4220761A (en) | 1978-09-12 | 1980-09-02 | Fujisawa Pharmaceutical Co., Ltd. | 7-[Substituted oximinoacetamido]-3-[hydroxy alkyltetrazolo]cephalosporin derivatives |
| DE2945248A1 (de) | 1978-11-13 | 1980-05-22 | Fujisawa Pharmaceutical Co | Cephem-verbindungen, verfahren zu ihrer herstellung und sie enthaltende antibakterielle pharmazeutische mittel |
| DE3177090D1 (en) * | 1980-12-31 | 1989-09-28 | Fujisawa Pharmaceutical Co | 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof |
| JP2519054B2 (ja) | 1986-06-09 | 1996-07-31 | 武田薬品工業株式会社 | 新規セフェム化合物 |
| AU1630988A (en) | 1987-05-30 | 1988-12-01 | Kyoto Pharmaceutical Industries, Ltd. | Cephalosporin compound and pharmaceutical composition thereof |
| JPH04221388A (ja) * | 1990-12-20 | 1992-08-11 | Asahi Chem Ind Co Ltd | セファロスポリン化合物およびその製造法 |
| TWI335332B (en) * | 2001-10-12 | 2011-01-01 | Theravance Inc | Cross-linked vancomycin-cephalosporin antibiotics |
| ITMI20012363A1 (it) | 2001-11-09 | 2003-05-09 | Antibioticos Spa | Metodo per la sintesi di catene laterali di cefalosporine |
| US6878686B2 (en) | 2002-05-24 | 2005-04-12 | Theravance, Inc. | Cross-linked glycopeptide-cephalosporin antibiotics |
| GB0416379D0 (en) | 2004-07-22 | 2004-08-25 | Sandoz Ag | Organic compounds |
| WO2006104141A1 (ja) | 2005-03-29 | 2006-10-05 | Shionogi & Co., Ltd. | ３－プロペニルセフェム誘導体 |
-
2014
- 2014-03-06 MD MDA20150099A patent/MD4719C1/ro active IP Right Grant
- 2014-03-06 BR BR112015022600A patent/BR112015022600A2/pt active Search and Examination
- 2014-03-06 WO PCT/US2014/021080 patent/WO2014164187A1/en active Application Filing
- 2014-03-06 JP JP2016500718A patent/JP6404309B2/ja active Active
- 2014-03-06 MX MX2015012146A patent/MX351963B/es active IP Right Grant
- 2014-03-06 CN CN201480013807.7A patent/CN105121417B/zh active Active
- 2014-03-06 UA UAA201509929A patent/UA115087C2/uk unknown
- 2014-03-06 EA EA201591708A patent/EA027911B1/ru unknown
- 2014-03-06 AU AU2014249611A patent/AU2014249611B2/en not_active Ceased
- 2014-03-06 KR KR1020157026105A patent/KR20150126368A/ko not_active Application Discontinuation
- 2014-03-06 ES ES14712945.6T patent/ES2634019T3/es active Active
- 2014-03-06 EP EP14712945.6A patent/EP2970164B1/en active Active
- 2014-03-06 US US14/198,975 patent/US9139542B2/en active Active
- 2014-03-06 SG SG11201507221VA patent/SG11201507221VA/en unknown
- 2014-03-06 CA CA2902724A patent/CA2902724A1/en not_active Abandoned
- 2014-03-06 TW TW103107729A patent/TWI627165B/zh not_active IP Right Cessation
- 2014-03-06 GE GEAP201413956A patent/GEP201706779B/en unknown
-
2015
- 2015-08-17 IL IL240600A patent/IL240600A0/en unknown
- 2015-09-11 PH PH12015502067A patent/PH12015502067A1/en unknown
-
2016
- 2016-03-07 HK HK16102556.4A patent/HK1214596A1/zh not_active IP Right Cessation
-
2018
- 2018-08-15 JP JP2018152961A patent/JP2018197256A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015022600A2 (pt) | 2017-07-18 |
| MX351963B (es) | 2017-11-06 |
| MD20150099A2 (ro) | 2016-02-29 |
| PH12015502067B1 (en) | 2016-01-25 |
| EA027911B1 (ru) | 2017-09-29 |
| PH12015502067A1 (en) | 2016-01-25 |
| HK1214596A1 (zh) | 2016-07-29 |
| ES2634019T3 (es) | 2017-09-26 |
| JP6404309B2 (ja) | 2018-10-10 |
| TWI627165B (zh) | 2018-06-21 |
| SG11201507221VA (en) | 2015-10-29 |
| EP2970164B1 (en) | 2017-05-03 |
| EA201591708A1 (ru) | 2016-01-29 |
| KR20150126368A (ko) | 2015-11-11 |
| IL240600A0 (en) | 2015-09-24 |
| CA2902724A1 (en) | 2014-10-09 |
| GEP201706779B (en) | 2017-11-27 |
| JP2018197256A (ja) | 2018-12-13 |
| EP2970164A1 (en) | 2016-01-20 |
| JP2016512257A (ja) | 2016-04-25 |
| AU2014249611B2 (en) | 2017-12-21 |
| AU2014249611A1 (en) | 2015-09-17 |
| MD4719C1 (ro) | 2021-05-31 |
| MX2015012146A (es) | 2015-11-25 |
| CN105121417B (zh) | 2017-11-17 |
| CN105121417A (zh) | 2015-12-02 |
| US9139542B2 (en) | 2015-09-22 |
| US20140275554A1 (en) | 2014-09-18 |
| TW201444810A (zh) | 2014-12-01 |
| MD4719B1 (ro) | 2020-10-31 |
| WO2014164187A1 (en) | 2014-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ726356A (en) | Processes for preparing antiviral compounds | |
| EP3290406A4 (en) | Novel crystal of uracil compound | |
| EP2999688A4 (en) | Process to prepare levulinic acid | |
| PH12016501941B1 (en) | Use of heterocyclic compounds for controlling nematodes | |
| MX359673B (es) | Preparacion de intermediarios de pirimidina utiles para la preparacion de maci tentano. | |
| PL2903959T3 (pl) | Sposób wytwarzania pochodnych kwasu cykloheksanopolikarboksylowego o małym udziale produktów ubocznych | |
| EP3307704A4 (en) | NOVEL METHOD FOR THE PRODUCTION OF ACRYLIC ACID WITH ACETALDEHYDE AS A MAJOR INNOVATION PRODUCT | |
| EP2968387A4 (en) | Methods of synthesizing substituted purine compounds | |
| EP2969140A4 (en) | One-step procedure for the purification of nucleic acids | |
| EP3329336A4 (en) | USE OF FILTERED BASE SPLINES FOR COMPENSATING SERVOINDUCED MOTION ERRORS | |
| EP3380482A4 (en) | CRYSTALLINE FORMS OF A THIENOPYRIMIDINE COMPOUND | |
| PH12015502067A1 (en) | Crystalline form of a substituted thiazolylacetic acid triethylamine salt | |
| EP3033331A4 (en) | Process for the purification of diaminophenothiazinium compounds | |
| EP3021849A4 (en) | Novel crystalline forms of pemetrexed tromethamine salts | |
| IN2013MU04056A (uk) | ||
| ZA201509355B (en) | Novel ureido derivatives of naphthalenesulfonic acids | |
| MX2016005511A (es) | Intermediarios y metodos para sintetizar derivados de calicheamicina. | |
| EP3023411A4 (en) | Production method of ketomalonic acid compound | |
| MX2014012822A (es) | Proceso para elaborar derivados de naftiridina. | |
| MX361673B (es) | Procedimiento para la preparación de intermediarios de ácido borónico. | |
| EP3414347A4 (en) | ADDITIVE FOR IMPROVING SEQUENCING THROUGH SYNTHETIC PERFORMANCE | |
| EP2989097A4 (en) | Improved processes for the preparation of linezolid using novel intermediates | |
| EP2980061A4 (en) | PROCESS FOR IMPROVING THE OPTICAL PURITY OF 2-HYDROXYCARBOXYLIC ACID OR ITS DERIVATIVE | |
| WO2015001565A3 (en) | "an improved process for the preparation of 3-aryloxy-3- phenylpropylamine and salt thereof" | |
| EA201400188A1 (ru) | Способ получения кристаллической формы i агомелатина |